AMANDA LUCAS: Open Payments
NPI 1871079822 · HOUMA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 19 payments from 9 companies in 2025. Trend: 2023 $379 · 2024 $245 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $94 |
| Sage Therapeutics, LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 2 | $34 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Supernus Pharmaceuticals, Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| GENZYME CORPORATION | 1 | $21 |
Products named: Ozempic, ZURZUVAE, MYFEMBREE, The Cologuard Plus Collection Kit, Phexxi, Qelbree, MOUNJARO, SYNTHROID.
Industry payments across LA — which companies pay providers there.
